Center-Authored Papers

Filters: Author is Bleakley, Marie  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Y
Yamamura T, Hikita J, Bleakley M, Hirosawa T, Sato-Otsubo A, Torikai H, Hamajima T, Nannya Y, Demachi-Okamura A, Maruya E et al..  2012.  HapMap SNP Scanner: an online program to mine SNPs responsible for cell phenotype.. Tissue antigens. 80(2):119-25. Abstract
P
Pollack SM, Jones RL, Farrar EA, Lai IP, Lee SM, Cao J, Pillarisetty VG, Hoch BL, Gullett A, Bleakley M et al..  2014.  Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cells.. Journal for immunotherapy of cancer. 2(1):36. Abstract
Pollack SM, Jungbluth AA, Hoch BL, Farrar EA, Bleakley M, Schneider DJ, Loggers ET, Rodler E, Eary JF, Conrad EU et al..  2012.  NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma.. Cancer. 118(18):4564-70. Abstract
O
Ochsenreither S, Majeti R, Schmitt T, Stirewalt D, Keilholz U, Loeb KR, Wood B, Choi YE, Bleakley M, Warren EH et al..  2012.  Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen.. Blood. 119(23):5492-501. Abstract
N
Nishida T, Hudecek M, Kostic A, Bleakley M, Warren EH, Maloney DG, Storb R, Riddell SR.  2009.  Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(14):4759-68. Abstract
M
McGoldrick SM, Bleakley ME, Guerrero A, Turtle CJ, Yamamoto TN, Pereira SE, Delaney CS, Riddell SR.  2013.  Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo.. Blood. 121(14):2796-803. Abstract
L
Li Y, Bleakley M, Yee C.  2005.  IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response.. Journal of immunology (Baltimore, Md. : 1950). 175(4):2261-9. Abstract
H
Hudecek M, Schmitt TM, Baskar S, Lupo-Stanghellini MT, Nishida T, Yamamoto TN, Bleakley M, Turtle CJ, Chang W-C, Greisman HA et al..  2010.  The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.. Blood. 116(22):4532-41. Abstract
G
Gardner RA, Finney O, Annesley C, Brakke H, Summers C, Leger K, Bleakley M, Brown C, Mgebroff S, Spratt K et al..  2017.  Intent to treat leukemia remission by CD19CAR T cells of defined formulation and dose in children and young adults.. Blood. Abstract
F
Fisher BT, Zaoutis TE, Park JR, Bleakley M, Englund JA, Kane C, Arceci RJ, Guinan E, Smith FO, Luan X et al..  2012.  Galactomannan Antigen Testing for Diagnosis of Invasive Aspergillosis in Pediatric Hematology Patients.. Journal of the Pediatric Infectious Diseases Society. 1(2):103-111. Abstract
D
Dossa RG, Cunningham T, Sommermeyer D, Medina-Rodriguez I, Biernacki MA, Foster K, Bleakley M.  2018.  Development of T cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse.. Blood. 131(1):108-120. Abstract
B
Bleakley M, Heimfeld S, Loeb KR, Jones LA, Chaney C, Seropian S, Gooley TA, Sommermeyer F, Riddell SR, Shlomchik WD.  2015.  Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts.. The Journal of clinical investigation. 125(7):2677-89. Abstract
Bleakley M, Riddell SR.  2011.  Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia.. Immunology and cell biology. 89(3):396-407. Abstract
Bleakley M, Heimfeld S, Jones LA, Turtle C, Riddell SR, Shlomchik W.  2014.  Engineering Human Peripheral Blood Stem Cell Grafts That Are Depleted of Naïve T Cells and Retain Functional Pathogen-Specific Memory T cells.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 20(5):705-16. Abstract
Bleakley M, Turtle CJ, Riddell SR.  2012.  Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation.. Expert review of hematology. 5(4):409-25. Abstract
Bleakley M, Otterud BE, Richardt JL, Mollerup AD, Hudecek M, Nishida T, Chaney CN, Warren EH, Leppert MF, Riddell SR.  2010.  Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells.. Blood. 115(23):4923-33. Abstract
Bleakley M, Kean L.  2014.  Future of allogeneic hematopoietic stem cell transplantation for chemotherapy-resistant pediatric acute leukemia: potential advances. International Journal of Hematologic Oncology. 3(5):319-323.